BUB1B与妇科恶性肿瘤

doi:10.16352/j.issn.1001-6325.2024.12.1717

基础医学与临床 ›› 2024, Vol. 44 ›› Issue (12): 1717-1721.doi: 10.16352/j.issn.1001-6325.2024.12.1717

BUB1B与妇科恶性肿瘤

候壹颖, 魏芳^*

山西医科大学第二医院妇产科,山西太原 030000

收稿日期:2023-12-28 修回日期:2024-05-13 出版日期:2024-12-05 发布日期:2024-11-26
通讯作者: ^*2yuanweifang@163.com
基金资助:
山西省自然科学基金(20210302123272)

BUB1B and gynecological malignant tumors

HOU Yiying, WEI Fang^*

Department of Gynecology, the Second Hospital of Shanxi Medical University, Taiyuan 030000, China

Received:2023-12-28 Revised:2024-05-13 Online:2024-12-05 Published:2024-11-26
Contact: ^*2yuanweifang@163.com

摘要/Abstract

摘要： 有丝分裂检查点丝氨酸/苏氨酸激酶B(BUB1B)能够通过防止细胞在一个或多个动点没有附着到纺锤体的情况下进入有丝分裂后期,维持有丝分裂染色体分离的高保真度,在信号转导和着丝粒稳定附着到微管过程中均发挥着主要作用。BUB1B表达失调可能影响细胞有丝分裂诱导非整倍体发生、染色体不稳定及异常的细胞生物学功能导致细胞恶性转化。本文对BUB1B在子宫内膜癌,卵巢癌及宫颈癌发生与发展中的作用作一简要回顾与分析。

关键词: BUB1有丝分裂检查点丝氨酸/苏氨酸激酶B(BUB1B), 妇科恶性肿瘤, 有丝分裂

Abstract: The BUB1 mitotic checkpoint serine/threonine kinase B (BUB1B) maintains a high fidelity of mitotic chromosome segregation by preventing the initiation of anaphase without the attachment of one or more kinetochore to the spindle, and plays a major role in both signal transduction and the stable attachment of kinetochore to microtubules. The dysregulated expression of BUB1B may affect the occurrence of mitosis-induced aneuploidy, chromosome instability and abnormal cell biological function, leading to cell malignant transformation. This review summarizes the role of BUB1B in the occurrence and development of gynecological malignant tumors.

Key words: the BUB1 mitotic checkpoint serine/threonine kinase B(BUB1B), gynecological malignant tumors, mitosis

中图分类号:

候壹颖, 魏芳. BUB1B与妇科恶性肿瘤[J]. 基础医学与临床, 2024, 44(12): 1717-1721.

HOU Yiying, WEI Fang. BUB1B and gynecological malignant tumors[J]. Basic & Clinical Medicine, 2024, 44(12): 1717-1721.

参考文献

[1]Zheng S, Guerrero-Haughton E, Foijer F. Chromosomal instability-driven cancer progression: interplay with the tumour microenvironment and therapeutic strategies[J]. Cells, 2023, 12: 2712.doi:10.3390/cells12232712.
[2]Lara-Gonzalez P, Pines J, Desai A. Spindle assembly checkpoint activation and silencing at kinetochores[J]. Semin Cell Dev Biol, 2021, 117: 86-98.
[3]Bloom CR, North BJ. Physiological relevance of post-translational regulation of the spindle assembly checkpoint protein BubR1[J]. Cell Biosci, 2021, 11: 76.doi: 10.1186/s13578-021-00589-2.
[4]Li X, Wang W, Ding X. Pan-cancer investigation of psoriasis-related BUB1B gene: genetical alteration and oncogenic immunology[J]. Sci Rep, 2023, 13: 6058.doi: 10.1038/s41598-023-33174-3.
[5]Terradas M, Capellá G, Valle L. Dominantly inherited hereditary nonpolyposis colorectal cancer not caused by MMR Genes[J]. J Clin Med, 2020, 9: 1954.doi: 10.3390/jcm9061954.
[6]Chung KS, Choi HE, Shin JS, et al. 6,7-Dimethoxy-3-(3-methoxyphenyl)isoquinolin-1-amine induces mitotic arrest and apoptotic cell death through the activation of spindle assembly checkpoint in human cervical cancer cells[J]. Carcinogenesis, 2013, 34: 1852-1860.
[7]Fu X, Chen G, Cai ZD, et al. Overexpression of BUB1B contributes to progression of prostate cancer and predicts poor outcome in patients with prostate cancer[J]. Onco Targets Ther, 2016, 9: 2211-2220.
[8]Komura K, Inamoto T, Tsujino T, et al. Increased BUB1B/BUBR1 expression contributes to aberrant DNA repair activity leading to resistance to DNA-damaging agents[J]. Oncogene, 2021, 40: 6210-6222.
[9]Fischer ES, Yu CWH, Bellini D, et al. Molecular mechanism of Mad1 kinetochore targeting by phosphorylated Bub1[J]. EMBO Rep, 2021, 22: e52242.doi: 10.15252/embr.202052242.
[10]Pan F, Chocarro S, Ramos M, et al. FOXM1 is critical for the fitness recovery of chromosomally unstable cells[J]. Cell Death Dis, 2023, 14: 430.doi: 10.1038/s41419-023-05946-2.
[11]Huang K, Zhang Y, Gong H, et al. Inferring evolutionary trajectories from cross-sectional transcriptomic data to mirror lung adenocarcinoma progression[J]. PLoS Comput Biol, 2023, 19: e1011122.doi: 10.1371/journal.pcbi.1011122.
[12]Guichard P, Laporte MH, Hamel V. The centriolar tubulin code[J]. Semin Cell Dev Biol, 2023, 137: 16-25.
[13]Chen Z, Liu X, Kawakami M, et al. CDK2 inhibition disorders centrosome stoichiometry and alters cellular outcomes in aneuploid cancer cells[J]. Cancer Biol Ther, 2023, 24: 2279241.doi:10.1080/15384047.2023.2279241.
[14]Sung H, Ferlay J, Siegel R L, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71: 209-249.
[15]Zhang Q, Wang Y, Xue F. ASPM, CDC20, DLGAP5, BUB1B, CDCA8, and NCAPG may serve as diagnostic and prognostic biomarkers in endometrial carcinoma[J]. Genet Res (Camb), 2022, 2022: 3217248.doi: 10.1155/2022/3217248.
[16]Chen Q, Ke H, Luo X, et al. Rare deleterious BUB1B variants induce premature ovarian insufficiency and early menopause[J]. Hum Mol Genet, 2020, 29: 2698-2707.
[17]Liu J, Liu L, Antwi PA, et al. Identification and validation of the diagnostic characteristic genes of ovarian cancer by bioinformatics and machine learning[J]. Front Genet, 2022, 13: 858466.doi:10.3389/fgene.2022.858466.
[18]蒋郁竹, 娄阁. 基于数据挖掘分析KIF14与SSK1在卵巢癌组织中的表达及临床意义[J]. 现代肿瘤医学, 2021, 29: 2800-2886.
[19]Lee YK, Choi E, Kim MA, et al. BubR1 as a prognostic marker for recurrence-free survival rates in epithelial ovarian cancers[J]. Br J Cancer, 2009, 101: 504-510.
[20]Mcgrogan B, Phelan S, Fitzpatrick P, et al. Spindle assembly checkpoint protein expression correlates with cellular proliferation and shorter time to recurrence in ovarian cancer[J]. Human Pathology, 2014, 45: 1509-1519.
[21]Tang Q, Atiq W, Mahnoor S, et al. Comprehensively analyzing the genetic alterations, and identifying key genes in ovarian cancer[J]. Oncol Res, 2023, 31: 141-156.
[22]Singh D, Vignat J, Lorenzoni V, et al. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative[J]. Lancet Glob Health, 2022, 11: e197-e206.
[23]李俞霆, 周常慧, 任敬秦. 生信分析宫颈癌脂质代谢酶相关基因表达及功能[J]. 生物技术, 2023, 33: 331-340.
[24]Wang L, Wang J, Jin Y, et al. Downregulation of Mad2 and BubR1 increase the malignant potential and nocoda-zole resistance by compromising spindle assembly checkpoint signaling pathway in cervical carcinogenesis[J]. J Obstet Gynaecol Res, 2019, 45: 2407-2418.
[25]谢芹. 硫利达嗪抑制宫颈癌SiHa细胞增殖及其机制研究[D]. 昆明:昆明医科大学, 2022:34-40.

BUB1B与妇科恶性肿瘤

BUB1B and gynecological malignant tumors

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 3

编辑推荐

Metrics

本文评价

[1]	刘林弟, 吕庆杰. GPSM2在肿瘤中作用机制的研究进展[J]. 基础医学与临床, 2024, 44(10): 1447-1450.
[2]	林港回, 蔡炳君, 周宇. CKAP2与恶性肿瘤[J]. 基础医学与临床, 2024, 44(10): 1470-1473.
[3]	薛丽白玉杰. 中心体在肿瘤发生及治疗中的作用[J]. 基础医学与临床, 2010, 30(4): 431-433.